Lux Capital

Lux Capital Research Investment Thesis Lux Capital, founded in 2000 by Josh Wolfe and Peter Hébert, operates with a distinctive mission: to "turn sci-fi into sci-fact." The firm believes in backing founders and companies working at the intersection of breakthrough science and transformational technology, solving the most vexing puzzles facing humanity. Rather than chasing consensus, Lux actively seeks counter-conventional solutions and contrarian positions in deep technology and emerging science. The fund explicitly champions founders who are "equal parts mad scientist and business mastermind," combining visionary thinking with operational excellence to reshape entire industries. Sector and Stage Focus Lux Capital takes a multi-stage, cross-sector approach to investing, with particular emphasis on artificial intelligence and data (AI/ML infrastructure, coding agents like Cognition/Devin), biotechnology and life sciences (therapeutics, genetic research, biotech infrastructure like Eikon Therapeutics), defense and aerospace (autonomous systems, defense technology like Anduril Industries), advanced manufacturing and robotics, energy and climate technology, semiconductors and hardware, and deep tech infrastructure including developer tools. Stage Flexibility Lux explicitly practices stage-agnostic investing, deploying capital from as little as $100,000 to $100 million+ in the same company. Recent fund (Lux Ventures IX, $1.5B, January 2026) shows median check size of approximately $25 million with significant variation. Investment Check Sizes and Approach Early-stage investments (pre-seed/seed) range from $100K-$10M, Series A/B range from $5M-$100M+, and growth/later-stage range from $25M-$100M+. The firm's approach emphasizes conviction over consensus, backing companies with moonshot potential rather than following herd behavior. Lead Tendency Lux Capital demonstrates a clear preference for leading rounds, particularly in early-stage opportunities where they've done discovery work. They consistently lead or co-lead seed rounds and participate significantly in Series A rounds. For later-stage investments, they participate actively but sometimes co-lead alongside other tier-one VCs like Founders Fund, Khosla Ventures, or Bain Capital. Recent Activity and Fund Status Lux Ventures IX closed on $1.5 billion in January 2026, the firm's largest fund ever. Initial target was $1.25B but the fund was oversubscribed. Headline investments include Cognition ($400M Series B, $10.2B valuation, September 2025), Erebor (led $350M round, January 2026), Anduril Industries (co-led $200M+), and numerous investments in Hugging Face, Runway, Applied Intuition, Eikon Therapeutics, Enveda, and Kallyope. The fund is actively deploying. Portfolio Overview Lux has invested in 299+ companies with 28 new investments in the last 12 months. Notable exits include MosaicML (acquired by Databricks for $1.3B), Rigetti Computing (quantum), Nozomi Networks (cybersecurity), and Planet Labs (earth imaging). Current marquee portfolio includes Anduril Industries (defense autonomous systems), Hugging Face (open-source AI), Runway (AI creative tools), Applied Intuition (autonomous vehicle simulation), Cognition/Devin (AI coding agent), Eikon Therapeutics (biotech imaging), and others across 200+ active companies. Team and Decision-Making The 44+ person team includes co-founders Josh Wolfe (visionary leader known for contrarian thinking) and Peter Hébert (operational expertise). Investment partners include Deena Shakir (life sciences focus), Brandon Reeves, Shahin Farshchi (hardware/robotics/manufacturing), Grace Isford, Shaq Vayda, David Yang, Lan Jiang, and Tess van Stekelenburg. Operations team includes Steven Brody (operations), Segolene Scarborough (finance), Adam Kalish (capital formation), Sean Traynor (legal). Venture partners include Brett McGurk (former diplomat, geo-strategy), Thomas Reardon, and others. Decision-making is partnership-based with input from relevant sector experts. Geographic and Founder Preferences Headquartered in New York City (920 Broadway) and Silicon Valley (Menlo Park, CA), the firm invests globally with particular strength in US tech hubs and select international markets. They seek visionary leaders with deep domain expertise (scientists, engineers, PhDs), operators combining mad scientist thinking with business acumen, risk-takers pursuing decade-long visions, and academic/research-connected founders. The firm explicitly pursues contrarian positions. Decision Process and Timeline Decisions follow a partnership model with multiple partners typically involved. Typical decision timeline for seed/early-stage is 2-8 weeks, Series A/B is 4-12 weeks, with deep tech/hardware potentially extending longer for technical validation. Founders report relatively streamlined decision processes compared to larger firms. What They Avoid Incremental improvements to existing categories, consensus investments and herd behavior, lacking technical founder credibility, markets without 10+ year time horizons, and consumer social apps (generally). Preferred Business Models & Sectors Strong conviction areas for 2025-2026 include AI/ML infrastructure and agents, advanced biotechnology, defense/aerospace/space, robotics and embodied intelligence, energy and climate tech, semiconductors and hardware, and manufacturing innovation. Preferred models are deep tech with structural advantages, B2B infrastructure and platforms, life sciences with clear therapeutic value, defense/national security technology, and AI infrastructure and tools. Notable Platform Services & Value-Add Beyond capital, Lux provides Riskgaming Initiative (educational articles, podcasts, immersive scenario games), Lux Labs ($100M academic research partnerships initiative launched 2025), academic pipeline through active university recruiting, technical support from firm's expertise, policy/government connections through advisors, follow-on capital reserves, and active board participation. Competitive Positioning Lux is positioned as a tier-one deep tech VC alongside Khosla Ventures and Founders Fund, a leader at the science/technology intersection with unique academic connections, a defense-tech specialist (top 3 alongside In-Q-Tel), and a multi-stage generalist. Key differentiators include technical depth with PhD scientists on team, long-term 10+ year vision backing, multi-stage flexibility from $100K to $100M+, deep academic integration, platform beyond capital, founder-friendly processes, and contrarian conviction investing.